Product Information

MIMVEY 1-0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.6409 per EA under NDC 00093545528. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 11, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Estradiol and Norethindrone Acetate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for MIMVEY 1-0.5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 76.3%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.